Signal Detection

Signal Detection is a pharmacovigilance process that systematically identifies potential safety signals—i.e., new risks or changes in known risks associated with medicinal products—through structured analysis of adverse event and related data to determine whether further evaluation and regulatory action are warranted.

1.8K

Publications

113.5K

Citations

6.1K

Authors

2K

Institutions

Publications per year

2017–2026

496

Authors

6.1K

  1. MS
    Miriam Sturkenboom

    Erasmus MC, Netherlands

    16 publications · 952 citations

    16

    h-index

  2. MH
    Manfred Hauben

    Pfizer (United States), United States

    15 publications · 794 citations

    13

    h-index

  3. IR
    I. Ralph Edwards

    Uppsala Monitoring Centre, Sweden

    11 publications · 846 citations

    11

    h-index

  4. MJ
    Martijn J. Schuemie

    Erasmus MC, Netherlands

    11 publications · 643 citations

    11

    h-index

  5. FS
    Francesco Salvo

    Bordeaux Population Health, France

    12 publications · 960 citations

    11

    h-index

1–5 of 6.1K

Venues

  1. Drug Safety

    67 publications · 4.5K citations

    35

    h-index

  2. Pharmacoepidemiology and Drug Safety

    56 publications · 5.7K citations

    31

    h-index

  3. Sensors and Actuators B Chemical

    29 publications · 1.2K citations

    21

    h-index

  4. Biosensors and Bioelectronics

    19 publications · 1.3K citations

    18

    h-index

  5. Analytica Chimica Acta

    22 publications · 798 citations

    18

    h-index

1–5